Published online May 2, 2005
PEDIATRICS Vol. 115 No. 5 May 2005, pp. 1351-1359 (doi:10.1542/peds.2004-1398)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (27)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, R. W.
Related Collections
Right arrow Premature & Newborn

Morphine, Hypotension, and Adverse Outcomes Among Preterm Neonates: Who’s to Blame? Secondary Results From the NEOPAIN Trial

Richard W. Hall, MD*, Shari S. Kronsberg, MS{ddagger}, Bruce A. Barton, PhD{ddagger}, Jeffrey R. Kaiser, MD, MA*, K.J.S. Anand, MBBS, DPhil*,§,||,¶ for the NEOPAIN Trial Investigators Group

* Department of Pediatrics
§ Department of Anesthesiology
|| Department of Neurobiology
Department of Pharmacology, University of Arkansas for Medical Sciences, Little Rock, Arkansas
{ddagger} Maryland Medical Research Institute, Baltimore, Maryland

Objectives. Hypotension occurs commonly among preterm neonates, but its cause and consequences remain unclear. Secondary data analyses from the NEOPAIN trial identified the clinical factors associated with hypotension and examined the contributions of morphine treatment or hypotension to severe intraventricular hemorrhage (IVH) (grades 3 and 4), any IVH (grades 1–4), or death.

Methods. In the NEOPAIN trial, 898 ventilated neonates between 23 and 32 weeks of gestation were enrolled, with equal numbers randomized to receive masked morphine or placebo infusions. Additional doses of open-label morphine were administered as necessary by medical staff members. IVH was diagnosed with centralized readings of early and late cranial ultrasonograms. Hypotension was assessed before study drug infusion, during the loading dose, and at 24 and 72 hours during study drug infusion. Logistic regression analyses with stepdown elimination identified the predictor factors associated with the hypotension, severe IVH, any IVH, or death outcomes at each time point.

Results. Hypotension was associated with 23 to 26 weeks of gestation, morphine infusions, severity of illness, additional morphine doses, and prior hypotension. Severe IVH was associated with shorter gestation, higher Clinical Risk Index for Babies scores, no prenatal steroids, pulmonary hemorrhage, hypotension before the loading dose, and morphine doses before intubation and at 25 to 72 hours. Neonatal deaths were associated with 23 to 26 weeks of gestation, higher Clinical Risk Index for Babies scores, pulmonary hemorrhage, patent ductus arteriosus, thrombocytopenia, and hypotension before the loading dose. Morphine infusions were not a significant factor in logistic models for severe IVH, any IVH, or death.

Conclusions. Preemptive morphine infusions, additional morphine, and lower gestational age were associated with hypotension among preterm neonates. Severe IVH, any IVH, and death were associated with preexisting hypotension, but morphine therapy did not contribute to these outcomes. Morphine infusions, although they cause hypotension, can be used safely for most preterm neonates but should be used cautiously for 23- to 26-week neonates and those with preexisting hypotension.

Key Words: morphine • hypotension • preterm neonates • outcomes • pain • intraventricular hemorrhage • drug toxicity

Abbreviations: IVH, intraventricular hemorrhage • PVL, periventricular leukomalacia • OR, odds ratio • CI, confidence interval • CRIB, Clinical Risk Index for Babies • BP, blood pressure • SGA, small for gestational age

Accepted Jan 4, 2005.




This article has been cited by other articles:


Home page
 Br J AnaesthHome page
K. J. S. Anand, B. J. Anderson, N. H. G. Holford, R. W. Hall, T. Young, B. Shephard, N. S. Desai, B. A. Barton, and for the NEOPAIN Trial Investigators Group
Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial
Br. J. Anaesth., August 29, 2008; (2008) aen248v2.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
J.-C. Roze, S. Denizot, R. Carbajal, P.-Y. Ancel, M. Kaminski, C. Arnaud, P. Truffert, S. Marret, J. Matis, G. Thiriez, et al.
Prolonged Sedation and/or Analgesia and 5-Year Neurodevelopment Outcome in Very Preterm Infants: Results From the EPIPAGE Cohort
Arch Pediatr Adolesc Med, August 1, 2008; 162(8): 728 - 733.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. Roka, K. T. Melinda, B. Vasarhelyi, T. Machay, D. Azzopardi, and M. Szabo
Elevated Morphine Concentrations in Neonates Treated With Morphine and Prolonged Hypothermia for Hypoxic Ischemic Encephalopathy
Pediatrics, April 1, 2008; 121(4): e844 - e849.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
K. D. Roberts, T. A. Leone, W. H. Edwards, W. D. Rich, and N. N. Finer
Premedication for Nonemergent Neonatal Intubations: A Randomized, Controlled Trial Comparing Atropine and Fentanyl to Atropine, Fentanyl, and Mivacurium
Pediatrics, October 1, 2006; 118(4): 1583 - 1591.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
N. N. Finer, R. J. Powers, C.-h. S. Ou, D. Durand, D. Wirtschafter, J. B. Gould, and for the California Perinatal Quality Care Collabor
Prospective Evaluation of Postnatal Steroid Administration: A 1-Year Experience From the California Perinatal Quality Care Collaborative
Pediatrics, March 1, 2006; 117(3): 704 - 713.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
K.J.S. Anand and R. W. Hall
Morphine, Hypotension, and Intraventricular Hemorrhage
Pediatrics, January 1, 2006; 117(1): 250 - 252.
[Full Text] [PDF]

Home page
 PediatricsHome page
J. M. Perlman
Morphine, Hypotension, and Intraventricular Hemorrhage: In Reply
Pediatrics, January 1, 2006; 117(1): 252 - 253.
[Full Text] [PDF]

Home page
 PediatricsHome page
J. M. Perlman
Morphine, Hypotension, and Intraventricular Hemorrhage in the Ventilated Premature Infant
Pediatrics, May 1, 2005; 115(5): 1416 - 1418.
[Full Text] [PDF]